Amanda Turkiewicz

Archived News and Events

Two Phase 3 Studies of the Tezacaftor/Ivacaftor Combination Leads to Improvements in Lung Function (FEV1) in People with Cystic Fibrosis

The research team at the Toronto Adult CF clinic would like  to share with the CF community the results of phase 3 clinical trials looking at the safety and efficacy of tezacaftor in combinati

Patient Education Needs Assessment

Your healthcare team at the Toronto Adult CF Clinic wants to know what CF-related topics you are interested in learning more about.

Inspirational stories

Here are some great stories of determination, perseverance and hard work...

Hand Hygiene

At the Toronto Adult CF Centre we are committed to infection control including Hand Hygiene.

New cystic fibrosis treatment approved by US FDA

The US Food and Drug Administration (FDA) approved Vertex’s new drug 

  • Read more
  • Dr. Elizabeth Tullis appointed to Cystic Fibrosis Canada Chair in Adult CF Research

    Our very own, Dr. Tullis has been appointed chair in adult CF research.

    Lung transplant survival rates good for Canadians with Cystic Fibrosis

    A recent by study by Dr Anne Stephenson shows that five year survival rates in CF are promising. <

    CF patient stories

    Some patients with CF struggle to breathe every day.

    Visit our new Quality Improvement (QI) tab

    Visit our new Quality Improvement (QI) tab to learn about projects currently going on in our clinic!